Skip to main content
. 2017 Apr 11;18(4):803. doi: 10.3390/ijms18040803
ALD Alcoholic liver disease
ALF Acute liver failure
ALP Alkaline phosphatase
ALT Alanine aminotransferase
APAP N-acetyl-para-aminophenol
AST Aspartate aminotransferase
ATP Adenosine triphosphate
CMV Cytomegalovirus.
CAM Causality assessment method
CK Cytokeratin
ccCK Caspase-cleaved CytoKeratin
CYP Cytochrome P450
Cys Cysteine
DILI Drug induced liver injury
EBV Epstein Barr virus
eDISH Evaluation of Drug-Induced Serious Hepatotoxicity
EMA European Medicines Agency
FDA Food and Drug Administration in Washington, DC
GLDH Glutamate dehydrogenase
GSH Glutathione
GST Glutathione S-transferase
HAV Hepatitis A virus
HBV Hepatitis B virus
HCV Hepatitis C virus
HEV Hepatitis E virus
HILI Herb induced liver injury
HLA Human leucocyte antigen
HMGB High Mobility Group Box (protein)
HSOS Hepatic sinusoidal obstructions syndrome.
IMI Innovative Medicines Initiative
INH Isonicotinic acid hydrazide
LTs Liver tests
MCSFR-1 Macrophage colony-stimulating factor receptor-1
microRNA Microarray RNA
NAFLD Non-alcoholic fatty liver disease
NAPQI N-acetyl-para-quinone imine
NASH Non-alcoholic steatohepatitis
MCSFR Macrophage colony stimulating factor receptor
PAs Pyrrolizidine alkaloids
PCR Polymerase chain reaction.
R Ratio
ROS Reactive oxygen species
RUCAM Roussel Uclaf Causality Assessment Method
SDH Sorbitol dehydrogenase
SAFE-T Safer and Faster Evidence-based Translation
SULT Sulfotransferase
TBIL Total bilirubin
TCM Traditional Chinese Medicine
UGT UDP-glucuronosyltransferases
ULN Upper limit of normal (range)
VZV Varicella zoster virus